Drugs / MAGNÓLIA NASAL GEL
last change Oct 2023 re-read 2 minutes ago

MAGNÓLIA NASAL GEL

Developed for
allergic rhinitis
Investigated by
EMS

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04670653 Aug 2022 → Jul 2023 allergic rhinitis EMS Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MAGNÓLIA NASAL GEL ClinicalTrials.gov intervention name — accepted as the source's own label NCT04670653
Route Intranasal “Magnólia nasal gel spray” NCT04670653